Paluchowska E, Jahnz-Rózyk K, Faber M, Samochocki Z
Kliniki Dermatologicznej, Instytutu Medycyny Wewnetrznej Centralnego Szpitala Klinicznego WAM.
Pol Merkur Lekarski. 1996 Nov;1(5):313-5.
Atopic dermatitis and bronchial asthma are genetically dependent diseases, connected with an over-synthesis of IgE antibodies, in which a chronic inflammation is characteristic for their pathogenesis. The coincidence of bronchial hyperresponsiveness and symptoms of atopic dermatitis suggests to investigate the degree of bronchial reactions in atopic dermatitis or asthma patients. The main goal of this analysis was to compare the pulmonary functional tests and the bronchial histamine induced reactiveness in 71 patients. The investigation included 27 atopic dermatitis patients, 12 asthma-prurigo patients and 32 bronchial asthma patients. All of them were tested with "Pneumoscreen" (Jaeger), in order to define: VC, FEV1, FEF50, and Raw. The bronchial reactiveness with 1% histamine solution, was tested on "Bronchoscreen" (Jaeger). In atopic dermatitis and asthma-prurigo patients, no obstructive ventilation impairment was found. The bronchial hyper-reactiveness to histamine was found in 11.1% of atopic dermatitis patients, 16.7% of asthma-prurigo patients and 78.1% of bronchial asthma patients. The coexistence of bronchial asthma and atopic dermatitis increases the degree of bronchial reactiveness.
特应性皮炎和支气管哮喘是与IgE抗体过度合成相关的遗传性疾病,慢性炎症是其发病机制的特征。支气管高反应性与特应性皮炎症状的并存提示应研究特应性皮炎或哮喘患者的支气管反应程度。该分析的主要目的是比较71例患者的肺功能测试和支气管组胺诱导的反应性。研究包括27例特应性皮炎患者、12例哮喘性痒疹患者和32例支气管哮喘患者。所有患者均使用“Pneumoscreen”(耶格公司)进行测试,以确定:肺活量(VC)、第一秒用力呼气容积(FEV1)、50%用力呼气流量(FEF50)和气道阻力(Raw)。使用1%组胺溶液对支气管反应性进行测试,使用“Bronchoscreen”(耶格公司)。在特应性皮炎和哮喘性痒疹患者中,未发现阻塞性通气障碍。在11.1%的特应性皮炎患者、16.7%的哮喘性痒疹患者和78.1%的支气管哮喘患者中发现了对组胺的支气管高反应性。支气管哮喘和特应性皮炎的并存会增加支气管反应性的程度。